We are live on ! Find out more
DERM

Dermira, Inc.
DERM

Delisted

DERM was delisted on the 19th of February, 2020.

129 hedge funds and large institutions have $857M invested in Dermira, Inc. in 2016 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 56 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 10

167% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 21

87% more capital invested

Capital invested by funds: $459M → $857M (+$398M)

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

33% more funds holding

Funds holding: 97129 (+32)

46% less call options, than puts

Call options by funds: $2.81M | Put options by funds: $5.18M

Holders
129
Holders Change
+32
Holders Change %
+32.99%
% of All Funds
3.44%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
42
Increased
56
Reduced
21
Closed
10
Calls
$2.81M
Puts
$5.18M
Net Calls
-$2.37M
Net Calls Change
-$1.75M
Name Holding Trade Value Shares
Change
Change in
Stake
NI
26
Numeric Investors
Massachusetts
$6.14M -$384K -13,925 -6%
NLVP
27
New Leaf Venture Partners
New York
$5.75M +$349K +12,660 +7%
DCM
28
DAFNA Capital Management
California
$5.66M +$600K +21,761 +13%
Axa
29
Axa
France
$5.52M +$2.66M +96,222 +104%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$5.16M -$280K -10,144 -5%
TA
31
Teachers Advisors
New York
$5.16M +$1.46M +52,898 +43%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$5.12M +$1.43M +51,657 +42%
CAM
33
Cormorant Asset Management
Massachusetts
$5.03M +$57.5K +2,083 +1%
ACP
34
Acuta Capital Partners
California
$4.97M +$4.69M +170,000 New
CCP
35
Clough Capital Partners
Massachusetts
$4.65M +$2.56M +92,600 +139%
IHM
36
Iguana Healthcare Management
New York
$4.39M +$2.07M +75,000 +100%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$3.91M +$1.21M +43,923 +49%
SEI Investments
38
SEI Investments
Pennsylvania
$3.8M +$3.54M +128,329 +8,454%
Bank of America
39
Bank of America
North Carolina
$3.75M +$593K +21,487 +20%
Point72 Asset Management
40
Point72 Asset Management
Connecticut
$3.73M +$1.41M +51,000 +66%
MIM
41
Monashee Investment Management
Massachusetts
$3.68M
CCM
42
Century Capital Management
Massachusetts
$3.6M +$1.77M +64,241 +110%
Allianz Asset Management
43
Allianz Asset Management
Germany
$3.46M -$33.1K -1,201 -1%
PCM
44
Palisade Capital Management
New Jersey
$3.33M -$1.36M -49,179 -30%
Ameriprise
45
Ameriprise
Minnesota
$3.32M +$793K +28,742 +34%
EI
46
EAM Investors
California
$3.26M +$3.07M +111,359 New
NIP
47
Nicholas Investment Partners
California
$3.25M +$711K +25,758 +30%
AC
48
Aisling Capital
New York
$3M -$24M -868,230 -89%
TCIM
49
TIAA CREF Investment Management
New York
$2.99M +$1.44M +52,104 +104%
BIM
50
BlackRock Investment Management
Delaware
$2.96M +$630K +22,840 +29%

DERM Hedge Fund Activity: Q2 2016 in Review

129 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Dermira, Inc. (DERM) for Q2 2016, worth a combined $857M — up 87% from $459M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new DERM positions and 10 closed out — a net gain of 32 holders — while 56 added to existing stakes and 21 trimmed.

The largest buyer was TimesSquare Capital Management, adding an estimated $30.4M. The largest seller was Aisling Capital, cutting an estimated $24M.

  • 129 institutional investors held Dermira, Inc. (DERM) as of Q2 2016, up from 97 in Q1 2016.
  • Funds reported $857M of Dermira, Inc. stock for Q2 2016, up 87% quarter-over-quarter.
  • 42 funds opened new Dermira, Inc. positions in Q2 2016 and 10 closed out, a net change of +32 holders.
  • The largest Dermira, Inc. buyer in Q2 2016 was TimesSquare Capital Management, an estimated $30.4M added.
  • The largest Dermira, Inc. seller in Q2 2016 was Aisling Capital, an estimated $24M sold.

Based on aggregated 13F filings for Q2 2016.